Note that some links may require subscriptions.
A diabetic federal worker on furlough because of the government shutdown rationed her insulin because she said she feared debt more than death. (CNN)
Eli Lilly’s soft-tissue sarcoma drug olaratumab (Lartruvo) missed its primary endpoint in a phase III confirmation trial and might have to be withdrawn from the market. The agent had received an accelerated approval in 2016, conditioned on showing a clinical benefit in a subsequent trial.
The American Psychological Association developed a new guideline for discussing masculinity with male patients, including boys and men. (ABC News)
Please don’t make us say this more than once: Semen injections are not a cure for back pain. (Fox News)
After yet another FDA rejection, biotech pioneer Immunomedics is 0 for 37, no approvals since the company opened its doors in 1982. (STAT)
So you have a penicillin allergy: Are you really sure about that? (Reuters)
Next time, try removing the pills from the plastic packet before you swallow them. (Newsweek)
Days after announcing their divorce, Walmart and CVS kiss and make up. (Reuters)
A reading assignment before your next airplane ride: “High altitude flatus expulsion” explained. (U.S. News & World Report)
Some of the stories behind the thousands of embryos stuck in “limbo” at fertility clinics. (CBS News)
Apple and private Medicare insurers are discussing strategies to make Apple Watches affordable for more senior citizens. (CNBC)
Scientists tracked down the specific brain cells responsible for pain perception, raising the possibility of strategies to make pain less “painful.” (NPR)
Morning Break is a daily guide to what’s new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: [email protected]